Liebman Jonathan Roy
Known title: DirectorCIK: 0002087040
Associated companies
Transaction History
| JAKK | ▲ Buy | Option Exercise | 4,827 | $118K | 9/9/2026 | View on chart |
| JAKK | ▲ Buy | Option Exercise | 4,827 | $118K | 9/9/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
JAKKS Pacific: Analysts eye 2027 catalysts
A recent analysis highlights potential growth drivers for JAKKS Pacific in 2027. The stock is currently trading within its 52-week range, with an average analyst target price of $28.50. The company's high beta suggests its price may move more sharply than the broader market.
JAKKS Pacific: Analysts eye 2027 catalysts. A recent analysis highlights potential growth drivers for JAKKS Pacific in 2027. The stock is currently trading within its 52-week range, with an average analyst target price of $28.50. The company's high beta suggests its price may move more sharply than the broader market.